Effect of siRNA-mediated downregulation of VEGF in Tca8113 cells on the activity of monocyte-derived dendritic cells

Oncology Letters

Volumn 3, Issue 4, 2012, Pages 885-892

  Ni, Yan Hong ^a,b   Wang, Zhi Yong ^b   Huang, Xiao Feng ^b   Shi, Pei Hua ^b   Han, Wei ^a,b   Hou, Ya Yi ^b   Hua, Zi Chun ^b   Hu, Qin Gang ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Dendritic cells; Oral squamous cell carcinoma; RNA interference; Vascular endothelial growth factor

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; SMALL INTERFERING RNA; T6 ANTIGEN; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; PHENOTYPE; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

EID: 84863162400     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.568     Document Type: Article

References (20)

1. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
2. O'Donnell RK, Kupferman M, Wei SJ, et al: Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 24: 1244-1251, 2005.
3. Franovic A, Holterman CE, Payette J, et al: Human cancers converge at the HIF-2alpha oncogenic axis. Proc Natl Acad Sci USA 106: 21306-21311, 2009.
4. Wang ZY, Shi PH, Huang XF, et al: Peripheral blood dendritic cells and vascular endothelial growth factor in oral squamous cell carcinoma: correlation analysis and in vitro study. Int J Oral Maxillofac Surg 39: 713-720, 2010.
5. Bennaceur K, Chapman J, Brikci-Nigassa L, et al: Dendritic cells dysfunction in tumour environment. Cancer Lett 272: 186-196, 2008.
6. Kyzas PA, Cunha IW and Ioannidis JP: Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis. Clin Cancer Res 11: 1434-1440, 2005.
7. Gallucci S, Lolkema M and Matzinger P: Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5: 1249-1255, 1999.
8. Fang L, Hu Q, Hua Z, Li S and Dong W: Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2. Int J Oral Maxillofac Surg 37: 847-852, 2008.
9. Wang Q, Huang Y, Ni Y, Wang H. and Hou Y: Sirna targeting midkine inhibits gastric cancer cells growth and induces apoptosis involved caspase-3,8,9 activation and mitochondrial depolarization. J Biomed Sci 14: 783-795, 2007.
10. Hasebe H, Nagayama H, Sato K, et al: Dysfunctional regulation of the development of monocyte-derived dendritic cells in cancer patients. Biomed Pharmacother 54: 291-298, 2000.
11. Ha PK and Califano JA: The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 14: 363-369, 2003.
12. Muller A, Sonkoly E, Eulert C, et al: Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. Int J Cancer 118: 2147-2157, 2006.
13. Brummelkamp TR, Bernards R and Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553, 2002.
14. Bhat TA and Singh RP: Tumor angiogenesis-a potential target in cancer chemoprevention. Food Chem Toxicol 46: 1334-1345, 2008.
15. Sasano H and Suzuki T: Pathological evaluation of angiogenesis in human tumor. Biomed Pharmacother 59 (Suppl 2): S334-S336, 2005.
16. Shi PH, Hu QG, Wang ZY, et al: Research on the correlation of vascular endothelial growth factor and dendritic cell in patients with oral squamous cell carcinoma. Zhonghua Kou Qiang Yi Xue Za Zhi 44: 135-139, 2009.
17. Théry C and Amigorena S: The cell biology of antigen presentation in dendritic cells. Curr Opin Immunol 13: 45-51, 2001.
18. Alfaro C, Suarez N, Gonzalez A, et al: Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Br J Cancer 100: 1111-1119, 2009.
19. Lee BN, Follen M, Rodriquez G, et al: Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions. Cancer 107: 999-1007, 2006.
20. Fricke I and Gabrilovich DI: Dendritic cells and tumor microenvironment: a dangerous liaison. Immunol Invest 35: 459-483, 2006.